An Open-Label PET/CT Imaging Study to Evaluate Brain Serotonin Transporter (SERT) Occupancy Following Single-Dose Administration of LG-0317 Tablets in Healthy Participants

NCT07708428 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Healthy Volunteers (HV)

Interventions

DRUG: Cohort 1: LG-0317 20 mg
DRUG: Cohort 1: LG-0317 40 mg
DRUG: Cohort 1: LG-0317 80 mg

Sponsor

LinGang Laboratory